IR Biosciences Holdings Inc. Stock Other OTC
Equities
IRBS
US46264M3034
Biotechnology & Medical Research
Financials (USD)
Sales 2009 | - | Sales 2010 | - | Capitalization | 1.2M |
---|---|---|---|---|---|
Net income 2009 | -6M | Net income 2010 | -5M | EV / Sales 2009 | - |
Net Debt 2009 | 5.81M | Net Debt 2010 | 3.67M | EV / Sales 2010 | - |
P/E ratio 2009 |
-0.37
x | P/E ratio 2010 |
-0.2
x | Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 03-06-30 | |
John N. Fermanis
DFI | Director of Finance/CFO | 70 | 04-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 03-06-30 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |